Company profile: Calibrium
1.1 - Company Overview
Company description
- Provider of biopharmaceutical research and development, focused on developing a portfolio of novel drug candidates for the treatment of diabetes and related metabolic diseases.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Calibrium
Ypsomed
HQ: Switzerland
Website
- Description: Provider of injection and infusion systems for self-medication, partnering with pharmaceutical and biotechnology companies for injection pens and autoinjectors. Delivers mylife Diabetescare solutions including infusion systems, blood glucose monitoring and therapy management, the mylife YpsoPump insulin pump, YpsoMate autoinjector, and mylife Loop automated insulin dosing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ypsomed company profile →
Beta Bionics
HQ: United States
Website
- Description: Provider of software to reduce the burden of diabetes care, offering the iLet Bionic Pancreas, an insulin delivery system that autonomously manages and administers insulin doses based on continuous glucose monitoring data, with Dexcom G7 CGM integration for real-time dose adjustments and compatibility with prefilled insulin cartridges for convenience and choice among insulin types.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Beta Bionics company profile →
Tandem Diabetes Care
HQ: United States
Website
- Description: Provider of insulin delivery solutions including the t:slim X2 insulin pump with color touchscreen that pairs with multiple CGM sensors and uses Control-IQ technology for automated insulin delivery; the Tandem Mobi System, a compact pump controllable via a compatible iPhone; Control-IQ Technology adjusting insulin based on CGM readings with automatic correction boluses and activity settings; infusion sets; and remote software updates.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tandem Diabetes Care company profile →
Biochemical Systems
HQ: Italy
Website
- Description: Provider of human and veterinary biochemistry analyzers, systems to measure glucose, cholesterol, and triglycerides, and accessories, serving laboratories, doctors offices, hospitals, and households.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biochemical Systems company profile →
Boston Therapeutics
HQ: United States
Website
- Description: Provider of novel compounds for unmet medical needs in diabetes and inflammatory diseases, focused on development and commercialization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Boston Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Calibrium
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Calibrium
2.2 - Growth funds investing in similar companies to Calibrium
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Calibrium
4.2 - Public trading comparable groups for Calibrium
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →